Host defense at the ocular surface

International Reviews of Immunology

Volumn 32, Issue 1, 2013, Pages 4-18

  Pearlman, Eric ^a   Sun, Yan ^a   Roy, Sanhita ^a   Karmakar, Mausita ^a   Hise, Amy G ^a   Szczotka Flynn, Loretta ^a   Ghannoum, Mahmoud ^a   Chinnery, Holly R ^b   McMenamin, Paul G ^c   Rietsch, Arne ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEAKIN UNIVERSITY   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Bacteria; Cornea; Epithelial cells; Pseudomonas aeruginosa; Toll like receptors

Indexed keywords

INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 1BETA; LIPOPEPTIDE; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN MD 2; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 11; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 9;

BACTERIAL GROWTH; BACTERIAL KERATITIS; BACTERICIDAL ACTIVITY; BONE MARROW CELL; CORNEA DISEASE; CORNEA STROMA; DISEASE SEVERITY; HOST RESISTANCE; INNATE IMMUNITY; NEUTROPHIL; NONHUMAN; OCULAR SURFACE DISEASE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RETINITIS; REVIEW; SERRATIA MARCESCENS; SUPPRESSOR CELL; TARGET CELL; TISSUE INJURY; TYPE III SECRETION SYSTEM; VISUAL IMPAIRMENT;

ANIMALS; CELL MOVEMENT; CONTACT LENSES; CYTOKINES; EPITHELIUM, CORNEAL; HUMANS; IMMUNITY, MUCOSAL; KERATITIS; LEUKOCIDINS; LIPOPOLYSACCHARIDES; LYMPHOCYTE ANTIGEN 96; NEUTROPHILS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TOLL-LIKE RECEPTORS;

EID: 84873306100     PISSN: 08830185     EISSN: 15635244     Source Type: Journal    
DOI: 10.3109/08830185.2012.749400     Document Type: Review

References (114)

1. www.who.int/blindness/Vision2020 report.pdf.
2. Saint Andre A, Blackwell NM, Hall LR, et al.The role of endosymbiotic Wolbachia bacteria in the pathogenesis of river blindness. Science 2002;295:1892-1895. (Pubitemid 34214126)
3. Turner JD, Langley RS, Johnston KL, et al. Wolbachia lipoprotein stimulates innate and adaptive immunity through Toll-like receptors 2 and 6 to induce disease manifestations of filariasis. J Biol Chem 2009;284:22364-22378.
4. Tamarozzi F, Halliday A, Gentil K, et al. Onchocerciasis: the role of Wolbachia bacterial endosymbionts in parasite biology, disease pathogenesis, and treatment. Clin Microbiol Rev 2011;24:459-468.
5. Knickelbein JE, Khanna KM, YeeMB, et al. Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency. Science 2008;322:268-271.
6. Gimenez F, Suryawanshi A, Rouse BT. Pathogenesis of herpes stromal keratitis - a focus on corneal neovascularization. Prog Retin Eye Res 2012 [Epub ahead of print].
7. Suryawanshi A,Mulik S, Sharma S, et al. Ocular neovascularization caused by herpes simplex virus type 1 infection results from breakdown of binding between vascular endothelial growth factor A and its soluble receptor. J Immunol 2011;186:3653-3665.
8. Karthikeyan RS, Leal SM, Jr., Prajna NV, et al. Expression of innate and adaptive immunemediators in human corneal tissue infected with Aspergillus or fusarium. J Infect Dis 2011;204:942-950.
9. Leal SM, Jr., Cowden S, Hsia YC, et al. Distinct roles for Dectin-1 and TLR4 in the pathogenesis of Aspergillus fumigatus keratitis. PLoS Pathog 2010;6:e1000976.
10. Clarke DW, Niederkorn JY. The immunobiology of Acanthamoeba keratitis. Microbes Infect 2006;8:1400-1405. (Pubitemid 43831694)
11. Iovieno A, Ledee DR,Miller D, Alfonso EC. Detection of bacterial endosymbionts in clinical Acanthamoeba isolates. Ophthalmology 2010;117:445-452.
12. Bhosai SJ, Bailey RL, Gaynor BD, Lietman TM. Trachoma: an update on prevention, diagnosis, and treatment. Curr Opin Ophthalmol 2012;23:288-295.
13. Leal SM, Jr., Pearlman E. The role of cytokines and pathogen recognition molecules in fungal keratitis - insights from human disease and animal models. Cytokine 2012;58:107-111.
14. Hazlett LD. Corneal response to Pseudomonas aeruginosa infection. Prog Retin Eye Res 2004;23:1-30. (Pubitemid 38177170)
15. Hazlett LD. Inflammatory response to Pseudomonas aeruginosa keratitis. Ocul Surf 2005;3:S139-S141.
16. Hazlett LD, Hendricks RL. Reviews for immune privilege in the year 2010: immune privilege and infection. Ocul Immunol Inflamm 2010;18:237-243.
17. Garreis F, Gottschalt M, Paulsen FP. Antimicrobial peptides as a major part of the innate immune defense at the ocular surface. Dev Ophthalmol 2012;45:16-22.
18. Dartt DA. Tear lipocalin: structure and function. Ocul Surf 2011;9:126-138.
19. Flanagan JL,Willcox MD. Role of lactoferrin in the tear film. Biochimie 2009;91:35-43.
20. Govindarajan B, Gipson IK.Membrane-tetheredmucins havemultiple functions on the ocular surface. Exp Eye Res 2011;90:655-663.
21. McDermott AM. The role of antimicrobial peptides at the ocular surface. Ophthalmic Res 2009;41:60-75.
22. Augustin DK,Heimer SR,TamC, et al. Role of defensins in corneal epithelial barrier function against Pseudomonas aeruginosa traversal. Infect Immun 2011;79:595-605.
23. Wu M,McClellan SA, Barrett RP, et al. Beta-defensins 2 and 3 together promote resistance to Pseudomonas aeruginosa keratitis. J Immunol 2009;183:8054-8060.
24. TamC,Mun JJ, Evans DJ, Fleiszig SM. Cytokeratins mediate epithelial innate defense through their antimicrobial properties. J Clin Invest 2012;122:3665-3677.
25. Pearlman E, Johnson A, Adhikary G, et al. Toll-like receptors at the ocular surface. Ocul Surf 2008;6:108-116.
26. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2011;11:373-384.
27. Zanoni I, Ostuni R,Marek LR, et al. CD14 controls the LPS-induced endocytosis of Toll-like receptor 4. Cell 2011;147:868-880.
28. Yarovinsky F, Zhang D, Andersen JF, et al. TLR11 activation of dendritic cells by a protozoan profilinlike protein. Science 2005;308:1626-1629. (Pubitemid 40807512)
29. Zhang D, Zhang G, Hayden MS, et al. A toll-like receptor that prevents infection by uropathogenic bacteria. Science 2004;303:1522-1526. (Pubitemid 38314423)
30. Shimazu R, Akashi S, Ogata H, et al.MD-2, amolecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J ExpMed 1999;189:1777-1782. (Pubitemid 29272694)
31. Viriyakosol S, Tobias PS, Kitchens RL, Kirkland TN. MD-2 binds to bacterial lipopolysaccharide. J Biol Chem 2001;276:38044-38051.
32. Visintin A, Mazzoni A, Spitzer JA, Segal DM. Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4. Proc Natl Acad Sci USA 2001;98:12156-12161. (Pubitemid 32959843)
33. Park BS, Song DH, Kim HM, et al. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 2009;458:1191-1195.
34. Gioannini TL, Teghanemt A, ZhangD, et al. Isolation of an endotoxin-MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations. Proc Natl Acad Sci USA 2004;101:4186-4191. (Pubitemid 38405904)
35. Brissette-Storkus CS, Reynolds SM, Lepisto AJ, Hendricks RL. Identification of a novelmacrophage population in the normal mouse corneal stroma. Invest Ophthalmol Vis Sci 2002;43:2264- 2271. (Pubitemid 34700657)
36. Chinnery HR, Pearlman E,McMenamin PG. Cutting edge: membrane nanotubes in vivo: a feature of MHC class II+ cells in the mouse cornea. J Immunol 2008;180:5779-5783.
37. Chinnery HR, Ruitenberg MJ, Plant GW, et al.The chemokine receptor CX3CR1 mediates homing of MHC class II-positive cells to the normal mouse corneal epithelium. Invest Ophthalmol Vis Sci 2007;48:1568-1574. (Pubitemid 351261340)
38. Hamrah P, Dana MR. Corneal antigen-presenting cells. Chem Immunol Allergy 2007;92:58-70. (Pubitemid 47102939)
39. Hamrah P, Huq SO, Liu Y, et al. Corneal immunity is mediated by heterogeneous population of antigen-presenting cells. J Leukoc Biol 2003;74:172-178. (Pubitemid 38040413)
40. Sun Y, Karmakar M, Roy S, et al. TLR4 and TLR5 on corneal macrophages regulate Pseudomonas aeruginosa keratitis by signaling through MyD88-dependent and -independent pathways. J Immunol 2010;185:4272-4283.
41. Huang X,DuW,McClellan SA, et al. TLR4 is required for host resistance in Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci 2006;47:4910-4916. (Pubitemid 46586392)
42. McClellan SA, Huang X, Barrett RP, et al. Macrophages restrict Pseudomonas aeruginosa growth, regulate polymorphonuclear neutrophil influx, and balance pro- and anti-inflammatory cytokines in BALB/c mice. J Immunol 2003;170:5219-5227. (Pubitemid 36554755)
43. Leal SM, Jr., Vareechon C, Cowden S, et al. Fungal antioxidant pathways promote survival against neutrophils during infection. J Clin Invest 2012;122:2482-2498.
44. Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 2006;6:173-182. (Pubitemid 43290987)
45. TamC,Mun JJ, Evans DJ, Fleiszig SM.Theimpact of inoculation parameters on the pathogenesis of contact lens-related infectious keratitis. Invest Ophthalmol Vis Sci 2010;51:3100-3106.
46. Adhikary G, Sun Y, Pearlman E. C-Jun NH2 terminal kinase (JNK) is an essential mediator of Tolllike receptor 2-induced corneal inflammation. J Leukoc Biol 2008;83:991-997. (Pubitemid 351959880)
47. Kumar A, Zhang J, Yu FS. Toll-like receptor 2-mediated expression of beta-defensin-2 in human corneal epithelial cells.Microbes Infect 2006;8:380-389. (Pubitemid 43214600)
48. Johnson AC, Li X, Pearlman E. MyD88 functions as a negative regulator of TLR3/TRIFinduced corneal inflammation by inhibiting activation of c-Jun N-terminal kinase. J Biol Chem 2008;283:3988-3996.
49. Ueta M,Hamuro J, Kiyono H, Kinoshita S. Triggering of TLR3 by polyI:Cin human corneal epithelial cells to induce inflammatory cytokines. Biochem Biophys Res Commun 2005;331:285-294. (Pubitemid 40545174)
50. Zhang J, Xu K, Ambati B, Yu FS. Toll-like receptor 5-mediated corneal epithelial inflammatory responses to Pseudomonas aeruginosa flagellin. Invest Ophthalmol Vis Sci 2003;44:4247-4254. (Pubitemid 37186258)
51. Chinnery HR, McLenachan S, Binz N, et al. TLR9 ligand CpG-ODN applied to the injured mouse cornea elicits retinal inflammation. AmJ Pathol 2012;180:209-220.
52. Sun Y, Pearlman E. Inhibition of corneal inflammation by the TLR4 antagonist Eritoran tetrasodium (E5564). Invest Ophthalmol Vis Sci 2009;50:1247-1254.
53. Ueta M, Nochi T, JangMH, et al. Intracellularly expressed TLR2s and TLR4s contribution to an immunosilent environment at the ocularmucosal epithelium. J Immunol 2004;173:3337-3347. (Pubitemid 39142043)
54. Visintin A, Halmen KA, Khan N, et al. MD-2 expression is not required for cell surface targeting of Toll-like receptor 4 (TLR4). J Leukoc Biol 2006;80:1584-1592. (Pubitemid 44904997)
55. Zhang J, Kumar A, Wheater M, Yu FS. Lack of MD-2 expression in human corneal epithelial cells is an underlying mechanism of lipopolysaccharide (LPS) unresponsiveness. Immunol Cell Biol 2009;87:141-148.
56. Roy S, Sun Y, Pearlman E. Interferon-gamma-induced MD-2 protein expression and lipopolysaccharide (LPS) responsiveness in corneal epithelial cells is mediated by Janus tyrosine kinase-2 activation and direct binding of STAT1 protein to the MD-2 promoter. J Biol Chem 2011;286:23753-23762.
57. Hazlett LD, Li Q, Liu J, et al. NKT cells are critical to initiate an inflammatory response after Pseudomonas aeruginosa ocular infection in susceptiblemice. J Immunol 2007;179:1138-1146.
58. Kumar A, Yin J, Zhang J, Yu FS.Modulation of corneal epithelial innate immune response to pseudomonas infection by flagellin pretreatment. Invest Ophthalmol Vis Sci 2007;48:4664-4670. (Pubitemid 351260984)
59. Redfern RL, Reins RY, McDermott AM. Toll-like receptor activation modulates antimicrobial peptide expression by ocular surface cells. Exp Eye Res 2011;92:209-220.
60. Rudner XL, Kernacki KA, Barrett RP,Hazlett LD. Prolonged elevation of IL-1 in Pseudomonas aeruginosa ocular infection regulatesmacrophage-inflammatory protein-2 production, polymorphonuclear neutrophil persistence, and corneal perforation. J Immunol 2000;164:6576-6582. (Pubitemid 30408844)
61. Karmakar M. Cutting Edge: IL-1β processing during Pseudomonas aeruginosa infection is mediated by neutrophil serine proteases and is independent of NLRC4 and Caspase-1. Cutting Edge J Immunol 2012;189(9):4231- 4235.
62. Gross O,Thomas CJ, Guarda G, Tschopp J. The inflammasome: an integrated view. Immunol Rev 2011;243:136-151.
63. Schroder K, Tschopp J. The inflammasomes. Cell 2010;140:821-832.
64. Miao EA, Alpuche-Aranda CM, Dors M, et al. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat Immunol 2006;7:569-575. (Pubitemid 43797337)
65. Miao EA, Ernst RK, Dors M, et al. Pseudomonas aeruginosa activates caspase 1 through Ipaf. Proc Natl Acad Sci USA 2008;105:2562-2567. (Pubitemid 351520553)
66. Miao EA,Mao DP, Yudkovsky N, et al. Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc Natl Acad Sci USA 2010;107:3076-3080.
67. Tomalka J,Ganesan S, Azodi E, et al. A novel role for the NLRC4 inflammasomeinmucosal defenses against the fungal pathogen Candida albicans. PLoS Pathog 2011;7:e1002379.
68. Franchi L, Stoolman J, Kanneganti TD, et al. Critical role for Ipaf in Pseudomonas aeruginosainduced caspase-1 activation. Eur J Immunol 2007;37:3030-3039. (Pubitemid 350131283)
69. Black RA, Kronheim SR, Cantrell M, et al. Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor. J Biol Chem 1988;263:9437-9442.
70. Hazuda DJ, Strickler J, Kueppers F, et al. Processing of precursor interleukin 1 beta and inflammatory disease. J Biol Chem 1990;265:6318-6322.
71. Mankan AK, Dau T, Jenne D, Hornung V.The NLRP3/ASC/Caspase-1 axis regulates IL-1beta processing in neutrophils. Eur J Immunol 2011;42(3):710-715.
72. Thakur A, Barrett RP, Hobden JA, Hazlett LD. Caspase-1 inhibitor reduces severity of Pseudomonas aeruginosa keratitis inmice. Invest Ophthalmol Vis Sci 2004;45:3177-3184. (Pubitemid 39121853)
73. ThakurA,BarrettRP,McClellanS,HazlettLD.Regulationof Pseudomonasaeruginosa corneal infection in IL-1 beta converting enzyme (ICE, caspase-1) deficient mice. Curr Eye Res 2004;29:225-233. (Pubitemid 40095005)
74. Wald D, Qin J, Zhao Z, et al. SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nat Immunol 2003;4:920-927. (Pubitemid 37098664)
75. Huang X, Hazlett LD, Du W, Barrett RP. SIGIRR promotes resistance against Pseudomonas aeruginosa keratitis by down-regulating type-1 immunity and IL-1R1 and TLR4 signaling. J Immunol 2006;177:548-556. (Pubitemid 43939168)
76. Huang X, Du W, Barrett RP, Hazlett LD. ST2 is essential for Th2 responsiveness and resistance to Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci 2007;48:4626-4633. (Pubitemid 351260980)
77. Jiang X,McClellan SA, Barrett RP, et al. VIP and growth factors in the infected cornea. Invest Ophthalmol Vis Sci 2011;52:6154-6161.
78. Jiang X, McClellan SA, Barrett RP, et al. Vasoactive intestinal peptide downregulates proinflammatory TLRs while upregulating anti-inflammatory TLRs in the infected cornea. J Immunol 2012;189:269-278.
79. Hazlett LD, McClellan SA, Barrett RP, et al. Spantide I decreases type I cytokines, enhances IL-10, and reduces corneal perforation insusceptible mice after Pseudomonasaeruginosa infection. Invest Ophthalmol Vis Sci 2007;48:797-807. (Pubitemid 351260715)
80. Zhou Z,BarrettRP,McClellan SA, et al. Substance P delays apoptosis, enhancing keratitis after Pseudomonas aeruginosa infection. Invest Ophthalmol Vis Sci 2008;49:4458-4467.
81. Burdelya LG, Krivokrysenko VI, Tallant TC, et al. An agonist of toll-like receptor 5 has radioprotective activity in mouse and primatemodels. Science 2008;320:226-230. (Pubitemid 351521417)
82. Vijay-KumarM, Aitken JD, Sanders CJ, et al. Flagellin treatment protects against chemicals, bacteria, viruses, and radiation. J Immunol 2008;180:8280-8285.
83. Kumar A, Gao N, Standiford TJ, et al. Topical flagellin protects the injured corneas from Pseudomonas aeruginosa infection.Microbes Infect 2010;12:978-989.
84. Kumar A, Hazlett LD, Yu FS. Flagellin suppresses the inflammatory response and enhances bacterial clearance in a murine model of Pseudomonas aeruginosa keratitis. Infect Immun 2008;76: 89-96.
85. Yu FS, Cornicelli MD, KovachMA, et al. Flagellin stimulates protective lungmucosalimmunity: role of cathelicidin-related antimicrobial peptide. J Immunol 2011;185:1142-1149.
86. Galan JE,Wolf-WatzH. Protein delivery into eukaryotic cells by type III secretionmachines. Nature 2006;444:567-573. (Pubitemid 44864429)
87. Hauser AR. The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat RevMicrobiol 2009;7:654-665.
88. Sato H, Frank DW. ExoU is a potent intracellular phospholipase. Mol Microbiol 2004;53: 1279-1290. (Pubitemid 39209104)
89. Barbieri JT, Sun J. Pseudomonas aeruginosa ExoS and ExoT. Rev Physiol Biochem Pharmacol 2004;152:79-92. (Pubitemid 44404359)
90. Kazmierczak BI, Mostov K, Engel JN. Epithelial cell polarity alters Rho-GTPase responses to Pseudomonas aeruginosa.Mol Biol Cell 2004;15:411-419. (Pubitemid 38146461)
91. Krall R, Sun J, Pederson KJ, Barbieri JT. In vivo rho GTPase-activating protein activity of Pseudomonas aeruginosa cytotoxin ExoS. Infect Immun 2002;70:360-367. (Pubitemid 34028636)
92. Engel J, Balachandran P. Role of Pseudomonas aeruginosa type III effectors in disease. Curr Opin Microbiol 2009;12:61-66.
93. Feltman H, Schulert G, Khan S, et al. Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa. Microbiology 2001;147:2659-2669. (Pubitemid 32976307)
94. Cowell BA,Weissman BA, Yeung KK, et al. Phenotype of Pseudomonas aeruginosa isolates causing corneal infection between 1997 and 2000. Cornea 2003;22:131-134. (Pubitemid 36701914)
95. Lee EJ, Cowell BA, Evans DJ, Fleiszig SM, et al. Contribution of ExsA-regulated factors to corneal infection by cytotoxic and invasive Pseudomonas aeruginosa in amurine scarification model. Invest Ophthalmol Vis Sci 2003;44:3892-3898. (Pubitemid 37047960)
96. Stover CK, Pham XQ, Erwin AL, et al. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 2000;406:959-964.
97. Angus AA, Lee AA, Augustin DK, et al. Pseudomonas aeruginosa induces membrane blebs in epithelial cells, which are utilized as a niche for intracellular replication and motility. Infect Immun 2008;76:1992-2001. (Pubitemid 351656131)
98. Angus AA, Evans DJ, Barbieri JT, Fleiszig SM.TheADP-ribosylationdomain of Pseudomonas aeruginosa ExoS is required for membrane Bleb-Niche formation and bacterial survival within epithelial cells. Infect Immun 2010;78(11):4500-4510.
99. Behlau I, Gilmore MS.Microbial biofilms in ophthalmology and infectious disease. Arch Ophthalmol 2008;126:1572-1581.
100. Mukherjee PK, Zhou G, Munyon R, Ghannoum MA. Candida biofilm: a well-designed protected environment.MedMycol 2005;43:191-208. (Pubitemid 40867493)
101. Szczotka-Flynn LB, Imamura Y, Chandra J, et al. Increased resistance of contact lens-related bacterial biofilms to antimicrobial activity of soft contact lens care solutions. Cornea 2009;28:918-926.
102. Szczotka-Flynn LB,Pearlman E,GhannoumM.Microbial contamination of contact lenses, lens care solutions, and their accessories: a literature review. Eye Contact Lens 2010;36:116-129.
103. Johnson AC,Heinzel FP, Diaconu E, et al. Activation of toll-like receptor (TLR)2, TLR4, and TLR9 in the mammalian cornea induces MyD88-dependent corneal inflammation. Invest Ophthalmol Vis Sci 2005;46:589-595. (Pubitemid 40270339)
104. Szczotka-Flynn L, Diaz M. Risk of corneal inflammatory events with silicone hydrogel and low dk hydrogel extended contact lens wear: a meta-analysis. Optom Vis Sci 2007;84:247-256. (Pubitemid 46624849)
105. Dong Q, Brulc JM, Iovieno A, et al. Diversity of bacteria at healthy human conjunctiva. Invest Ophthalmol Vis Sci 2011;52:5408-5413.
106. HumeEB,Conerly LL,Moreau JM, et al. Serratiamarcescens keratitis: strain-specific corneal pathogenesis in rabbits. Curr Eye Res 1999;19:525-532. (Pubitemid 30052880)
107. Willcox MD, Hume EB. Differences in the pathogenesis of bacteria isolated from contact-lensinduced infiltrative conditions. Aust N Z J Ophthalmol 1999;27:231-233. (Pubitemid 29429695)
108. Sun Y, KarmakarM, Taylor PR, et al. ExoS and ExoT ADP ribosyltransferase activitiesmediate Pseudomonas aeruginosa keratitis by promoting neutrophil apoptosis and bacterial survival. J Immunol 2012;188:1884-1895.
109. Zhou R, Zhang R, Sun Y, et al. Innate immune regulation of Serratia marcescens induced corneal inflammation and infection. Invest Ophthalmol Vis Sci 2012;53(11):7382-7388.
110. Bharathi MJ, Ramakrishnan R, Meenakshi R, et al. Microbial keratitis in South India: influence of risk factors, climate, and geographical variation. Ophthalmic Epidemiol 2007;14:61-69. (Pubitemid 46676497)
111. Hume EB, Cole N, Garthwaite LL, et al. A protective role for IL-6 in staphylococcal microbial keratitis. Invest Ophthalmol Vis Sci 2006;47:4926-4930. (Pubitemid 46586394)
112. Moore QC, 3rd, McCormick CC, Norcross EW, et al. Development of a Streptococcus pneumoniae keratitismodel inmice. Ophthalmic Res 2009;42:141-146.
113. Sun Y, Fox T, Adhikary G, et al. Inhibition of corneal inflammation by liposomal delivery of shortchain, C-6 ceramide. J Leukoc Biol 2008;83:1512-1521. (Pubitemid 351960333)
114. Sun Y, Zhang R, Gadek TR, et al. Corneal inflammation is inhibited by the LFA-1 antagonist, lifitegrast (SAR 1118). J Ocul Pharmacol Ther 2013;29:In press.